Breast Cancer News and Research

Latest Breast Cancer News and Research

Walgreens, aVinci Media launch initiative for breast cancer awareness, raises more than $50,000

Walgreens and aVinci® Media have launched a very successful national initiative to raise vital funds and awareness for breast cancer research and support. On Oct. 7, Walgreens offered aVinci's My Personal Movie slideshow DVDs, which normally retail for $19.99, for only $1.

19 Oct 2009

24 Hour Data to support breast cancer awareness, to donate 5% of its October sales to NBCF

24 Hour Data today announced its support for Breast Cancer Awareness Month. In an effort to raise awareness about the importance of early detection of breast cancer, the Dallas-based company will donate 5% of its October sales to the National Breast Cancer Foundation, Inc. (NBCF).

19 Oct 2009

Philippines and Malaysian regulatory agencies approve Celsion’s Phase III Thermodox trial

Celsion Corporation announced today that it has received approval from the regulatory agencis in the Philippines and Malaysia for its Pivotal Phase III primary liver cancer Clinical Trial Application.

19 Oct 2009

Hologic opens new facility in Hong Kong

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced the opening of its new Asia Pacific regional offices and the Hologic Asia Pacific Center for Health Sciences Education in Hong Kong.

From Hologic, Inc. 19 Oct 2009

New data on Phase 3 SIMPONI clinical trials for rheumatoid arthritis

New long-term data from two pivotal, Phase 3 clinical trials showed that patients with active rheumatoid arthritis (RA) receiving SIMPONI(TM) (golimumab) every four weeks achieved sustained improvements in signs and symptoms and physical function response through one year. These new data were presented today at the 2009 American College of Rheumatology (ACR) Annual Scientific Meeting.

19 Oct 2009

Amgen receives Complete Response Letter for the Biologic License Applications for Prolia from FDA

Amgen Inc. today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter for the Biologic License Applications (BLA) for Prolia(TM) (denosumab) in the treatment and prevention of postmenopausal osteoporosis.

19 Oct 2009

New decision-making tool offers breast reconstruction options post cancer surgery

A computer-based decision-making aid may make it possible for more women to have breast reconstruction after surgical treatment for cancer.

19 Oct 2009

Physical therapists can promote early diagnosis of breast cancer-related lymphedema

As breast cancer awareness month is observed during October, the American Physical Therapy Association (APTA) is hoping to shine a spotlight on lymphedema, a chronic, debilitating and often irreversible side effect of cancer treatment.

19 Oct 2009

Institute Curie Hospital in France adds another TomoTherapy radiation therapy system

TomoTherapy Incorporated announced today that the Institute Curie Hospital in France has purchased a second TomoTherapy® radiation therapy system, to support the increasing demand for intensity-modulated radiation therapy (IMRT). The Institute Curie Hospital has been treating cancer patients with TomoTherapy technology since March 2007, when it became the first hospital in France to adopt the technology.

19 Oct 2009

Qforma introduces new phase of its healthcare database

Patients diagnosed with breast cancer or depression who are seeking a medical expert in their own community to guide them through treatment now have a place to start. Qforma, an advanced analytics and predictive modeling company, today introduced the new phase of its first-of-its-kind healthcare database "Most Influential Doctors," or MID, presented by USA TODAY.

19 Oct 2009

China's SFDA approves Celsion’s global Phase III ThermoDox HEAT trial for treating liver cancer

Celsion Corporation announced today that it has received official approval from China’s State Food and Drug Administration (“SFDA”) for its Clinical Trial Application for ThermoDox that permits Celsion to include Chinese clinical trial sites in its Phase III ThermoDox HEAT trial for the treatment of primary liver cancer, also known as hepatocellular carcinoma (HCC).

15 Oct 2009

Access Pharmaceuticals' update on its European commercial launch of Mugard

ACCESS PHARMACEUTICALS, INC. today provided an update on its European commercial launch of MuGard, an FDA approved treatment for oral mucositis, a debilitating side effect of radiation treatment and chemotherapy.

15 Oct 2009

ADI and CeTeCancer collaborate for research project

Radient Pharmaceuticals Corporation, a US-based pharmaceutical company, announced today it has entered into a collaboration agreement through its wholly owned subsidiary AMDL Diagnostics, Inc. (ADI) with CeTeCancer -- a Chilean-based research laboratory -- to validate the effectiveness of Radient Pharmaceuticals' Onko-Sure™ in vitro diagnostic (IVD) cancer test as an early detection and prevention test for lung cancer.

15 Oct 2009

Purina Cat Chow's initiative for breast cancer awareness

Purina® Cat Chow® understands the unique bond between an owner and their cat and the connection they share. Inspired by a cancer survivor’s touching story of the role her cat played during her battle with cancer, Purina Cat Chow began a partnership with Susan G. Komen for the Cure®. A recent Purina Cat Chow national survey of breast cancer survivors with cats underscores this connection by revealing 84 percent of respondents felt their cat had a calming effect during their battle with breast cancer and 76 percent of respondents received daily support from their cat during treatment.

15 Oct 2009

Slavica BioChem scientists reverse multidrug resistance in lung cancer using small molecules

HTDS - The issuer's Serbia based operating subsidiary Slavica BioChem www.slavicabiochem.com brings attention to its Mindup Bioresearch cancer project working on molecular origins of lung cancer: prospects for personalized prevention and therapy. On October 8 2009, the company posted a filing on Pink Sheets titled MindUp Cancer Project.

15 Oct 2009

Genetic mutation implicated in breast and ovarian cancers could also have a role in causing heart failure: Study

A genetic mutation implicated in breast and ovarian cancers could also have a role in causing heart failure, according to a new study reported at the 95th annual Clinical Congress of the American College of Surgeons.

15 Oct 2009

Samsung launches campaign to support breast cancer care and prevention

Today, Samsung launches its very first European Breast Cancer Awareness Day with a star-studded celebratory Afternoon Tea event at the UK’s Westfield London – Europe’s largest shopping centre.

15 Oct 2009

Five research teams receive $2.4 million to help breast cancer survivors

A total of $2.4 million has been awarded to five research teams in the Canadian Breast Cancer Research Alliance/Canadian Breast Cancer Foundation Special Research Competition on Psychosocial Aspects of Breast Cancer.

15 Oct 2009

Biosante Pharmaceuticals, Cell Genesys successfully complete merger

BioSante Pharmaceuticals, Inc. and Cell Genesys, Inc., today announced the successful completion of their previously announced merger of Cell Genesys with and into BioSante, with BioSante as the surviving company, under which BioSante now has acquired all of the outstanding shares of Cell Genesys common stock.

15 Oct 2009

Positive data from ZIOPHARM's palifosfamide sarcoma Phase II trial

ZIOPHARM Oncology, Inc. announced today positive top line interim data from the multicenter randomized Phase II trial of palifosfamide (ZymafosTM, ZIO-201) treating patients with unresectable or metastatic soft tissue sarcoma. The analysis evaluated 62 patients treated as of the end of September, with 58 being analyzed.

14 Oct 2009

Breast Cancer News and Research

Latest Breast Cancer News and Research

Walgreens, aVinci Media launch initiative for breast cancer awareness, raises more than $50,000

24 Hour Data to support breast cancer awareness, to donate 5% of its October sales to NBCF

Philippines and Malaysian regulatory agencies approve Celsion’s Phase III Thermodox trial

Hologic opens new facility in Hong Kong

New data on Phase 3 SIMPONI clinical trials for rheumatoid arthritis

Amgen receives Complete Response Letter for the Biologic License Applications for Prolia from FDA

New decision-making tool offers breast reconstruction options post cancer surgery

Physical therapists can promote early diagnosis of breast cancer-related lymphedema

Institute Curie Hospital in France adds another TomoTherapy radiation therapy system

Qforma introduces new phase of its healthcare database

China's SFDA approves Celsion’s global Phase III ThermoDox HEAT trial for treating liver cancer

Access Pharmaceuticals' update on its European commercial launch of Mugard

ADI and CeTeCancer collaborate for research project

Purina Cat Chow's initiative for breast cancer awareness

Slavica BioChem scientists reverse multidrug resistance in lung cancer using small molecules

Genetic mutation implicated in breast and ovarian cancers could also have a role in causing heart failure: Study

Samsung launches campaign to support breast cancer care and prevention

Five research teams receive $2.4 million to help breast cancer survivors

Biosante Pharmaceuticals, Cell Genesys successfully complete merger

Positive data from ZIOPHARM's palifosfamide sarcoma Phase II trial

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Breast Cancer News and Research

Latest Breast Cancer News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in